Conditions: PBC Primary Biliary Cirrhosis
Keywords: PBC
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 66
Healthy volunteers: no

Brief summary:
The study is a randomized, double-blind, placebo-controlled, multicenter study. It is a 13-week Phase 2 study in adults with primary biliary cirrhosis designed to compare the effect of daily dosing with UDCA in combination with LUM001 or placebo.

Detailed description:

Arms:
arm 1: Administered orally once daily arm 2: Administered orally once daily

Interventions: intervention 1: LUM001 intervention 2: Placebo intervention 3: Ursodeoxycholic Acid
Intervention descriptions: intervention 1: None intervention 2: None intervention 3: None

Protocol document: